CSE: MGRO | OTC: MGROF | FRA: 0C0

Our Presentation

Cap Table

MustGrow is publicly traded (CSE:MGRO) (OTCQX:MGROF) (FRA:0C0) agricultural biotech company focused on providing natural science-based biological solutions for high value crops, including fruit & vegetable cultivation. 

 

CAPITAL STRUCTURE
Basic Shares Outstanding 49,209,237
Options 3,950,000
Warrants 1,940,304
Fully-Diluted Shares Outstanding 55,099,541
Insider Ownership (~20%) 9,824,904
CSE Average Volume (3 month) 29,400
Previous Capital Spent C$15,000,000
Cash Position C$8,000,000
Debt C$800,000

Natural Technology Platform with the Efficacy of Synthetic Chemicals

  • 100% owned patented mustard-derived technology; harnessing the natural defense mechanism of the mustard seed.
  • MustGrow’s natural biological solutions to replace synthetic chemicals used in high value crops such as fruit & vegetables and other industries.
  • Regulatory agencies are restricting or banning existing synthetic chemistries leaving limited alternatives.
  • Consumers are demanding healthy, natural and organic products.
  • Producers want to protect their crops with bilogicals but only if they work -- may bilogicals have as today not met performance expectations.
  • Agchem companies are actively investing in more sustainable natural technologies to replace or compliment synthetic chemicals.
  • Sustainable farming practices are critical to feed a growing global
    population on a finite amount of land.

Technology Platform with Application in Many Markets

  • Preplant Soil Biofumigant for multiple crops such as fruit, vegetable, turf and ornamental crops.
  • Bioherbicide with unique mode of action for organic acres, home & garden and jurisdictions where glyphosate is out of favor or banned.
  • Postharvest Biopesticide for storage and food preservation (F&V, bulk grain, shipping containers and food borne pathogens).

Technology Pipeline

FINANCIAL STATEMENTS

2022
Financials

Q1-2022

Q2-2022

  • Financials
  • MD&A

    Q3-2022

    • Financials
    • MD&A

    Q4-2022

    • Financials
    • MD&A

      2021
      Financials

      2020 Financials

      Q1-2021

      Q3-2021

      Q1-2020

      Q3-2020

      Q4-2020

      ANNUAL INFORMATION FORM

      2020 & 2021

      Year End 2020

        Year End 2021

          News Releases